In Conversation

USA Pharma Report 2020
Latest Reports
USA Pharma Report 2020
- 2020
The inaugural edition of the US Healthcare and Life Sciences Review has collated comments and insights from stakeholders across regulators, health insurers, pharma and biotech companies, as well as patient and industry associations, to provide an incisive snapshot of the US healthcare industry during one of its most defining periods, look at how far the sector has come and ultimately, how much further still it has to go, in order to achieve its fundamental mission: delivering innovative, quality and life-changing therapies in an accessible and sustainable manner. This exclusive new report is an extensive compilation of insights into the…
USA Pharma Data Report October 2020
Latest Reports
USA Pharma Data Report October 2020
- 2020
HCLS Review USA Data is an extensive compilation of data and infographics from the world’s largest and most important pharmaceutical market. US sales of drugs accounted for 48 percent of the global market for pharmaceuticals in 2019 and pharma market spending is on the rise, with Americans projected to be spending between USD 635 and 655 billion on medicine by 2023. Moreover, the USA is the world’s largest research and development engine, with an estimated USD 60 billion spent every year for this purpose, helping create the innovative treatments of tomorrow. This exclusive new 19-page report contains up-to-date information…
We use cookies to ensure that we give you the best experience on our site. For more info click here